The NIH’s National Center for Advancing Translational Sciences (NCATS), the ITM’s parent organization, now offers a comprehensive Pharmaceutical Collection. This tool, available to all ITM investigators, is a collection of molecular entities for screening, which can be used to validate new disease models and better understand the molecular details of disease and treatments. With 2,5000 molecular entities available for your use, take advantage of this accessible collection to help your translational research!
Source: NCATS